is wegovy a tirzepatide or semaglutide Diabetes drug linked to more significant weight loss than tirzepatide injection vs oral Semaglutide

Zweytick, D

It is essential to inform your healthcare provider if you are taking both medications so they can monitor for potential additive effects and adjust dosing as needed

However, accessibility, affordability, physician supervision, and long-term monitoring remain important considerations for widespread clinical adoption

In line with NICE TA875, semaglutide (Wegovy) should only be prescribed within specialist weight management services, with treatment typically limited to two years on the NHS

Researchers are still mapping the fuller picture

If you experience any suspected side effects from your medication, report them to the MHRA Yellow Card Scheme